MERCK'S ANTI-VIRAL COVID-19 PILL TO BE MADE IN GTA

Dec 06, 2021

By Bob Komsic

Share on
While awaiting Health Canada approval, Merck has announced it intends to produce its antiviral COVID-19 pill in Whitby.
The drug company has invested $19-million to increase production at Thermo Fisher Scientific’s facility in the east-end of the GTA.
The drug, one of the first treatment for non-hospitalized COVID patients, works by block the enzyme essential for viral replication.
Merck’s preliminary clinical trial showed the pill reduced the risk of hospitalization or death by 50% in patients with mild or moderate COVID.
However, an updated news release from the drug company late last month says the reduced risk was actually lower, at 30%.
The federal government announced last week Canada had a signed agreement to buy 500,000 courses of the drug with an option to purchase another 500,000 if Health Canada approves.
Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: